Development of an enzyme-linked immunosorbent assay for serotyping Ureaplasma urealyticum strains using monoclonal antibodies

Citation
F. Echahidi et al., Development of an enzyme-linked immunosorbent assay for serotyping Ureaplasma urealyticum strains using monoclonal antibodies, CL DIAG LAB, 8(1), 2001, pp. 52-57
Citations number
31
Categorie Soggetti
Immunology
Journal title
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
ISSN journal
1071412X → ACNP
Volume
8
Issue
1
Year of publication
2001
Pages
52 - 57
Database
ISI
SICI code
1071-412X(200101)8:1<52:DOAEIA>2.0.ZU;2-K
Abstract
Ureaplasma urealyticum comprises 14 serotypes, The existing serotyping meth ods all use polyclonal antibodies. These methods are time-consuming and lab or-intensive, and they cannot always be performed on primary isolates; in a ddition, the results are difficult to interpret. We developed a new enzyme- linked immunosorbent assay (ELISA) method using serotype-specific monoclona l antibodies (MAbs) to enable the serotyping of U, urealyticum isolates fro m primary broth cultures. Each of the 14 serotype reference strains was tes ted against 14 selected MAbs, Homologous reactions were very strong, while heterologous reactions were negligible, Three cross-reactions were observed : MAb 5 cross-reacted with serotype 2, MAb 14 cross-reacted with serotype 3 , and MAb 8 cross-reacted with serotype 13, Despite the cross-reactions obs erved, all the serotype reference strains of U, urealyticum could be identi fied and differentiated using a combination of MAbs, Reproducibility was an alyzed with a fractionated antigenic preparation and with several freshly p repared antigens of the same strain. No significant interrun variation was found with the fractionated antigen, but significant variations in optical density (OD) values were found when freshly prepared antigens were tested. However, the variation in OD values did not influence the overall interpret ation of the ELISA: reactions with homologous MAbs were always prominent co mpared to those of the negative controls. This newly developed ELISA using MAbs seems promising for serotyping of U, urealyticum clinical isolates.